Skip to content

A study to assess the effects of an injection, greater occipital nerve block in the management of neck pain related headache

A study to assess the effects of greater occipital nerve block in the management of cervicogenic headache

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013420
Enrollment
62
Registered
2018-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cervicogenic headache

Interventions

Intervention1: Greater occipital nerve block: Diagnostic block followed by therapeutic block after 2 weeks Control Intervention1: Conventional management: Pharmacological & non pharmacological managem

Sponsors

R G Kar Medical College Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Unilateral or side-dominant headache without side shift or unilateral both side. Pain localized to the neck and occipital region and/or projected to forehead, orbital region, temples, vertex or ears. Restriction of the range of motion (ROM) in the neck. Ipsilateral neck, shoulder, or arm pain of non-radicular or radicular nature. Precipitation of headache by neck movement and/or sustained awkward head positioning . Precipitation of headache by external pressure over the upper cervical or occipital region on the symptomatic side. Radiological examination reveals Movement abnormalities in flexion/extension or Abnormal posture Headache for the past 3 months at least once per week . No improvement of headache with conservative managements. Improvement of pain within 30 minutes of diagnostic greater occipital nerve block.

Exclusion criteria

Exclusion criteria: Congenital abnormalities of the cervical spine . Radiological evidence of cervical spondylosis or osteochondrosis . Myofascial trigger points are the cause . Contraindication or History of adverse reaction to anesthetic agents or corticosteroids . Prior intervention or surgery for treatment of headache . Evidence of impaired sensation in the Greater occipital nerve dermatome region . Evidence of cranial defect/abnormality near target injection site . Untreated cutaneous infection, systemic illness, or immunocompromised state History of bleeding tendency or use of anticoagulants . Patientâ??s refusal.

Design outcomes

Primary

MeasureTime frame
Pain severity Numeric Rating ScaleTimepoint: 1 Week 4 Weeks

Secondary

MeasureTime frame
Pain severity Numeric Rating ScaleTimepoint: 12 Weeks

Countries

India

Contacts

Public ContactDr Pankaj Kumar Mandal

R.G.Kar Medical College & Hospital

sasmal.doc@gmail.com9474756427

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026